Biomarkers continue to show promise in their potential to predict longer term clinical outcomes-both pain and structural progression in osteoarthritis, but they are still a way off surpassing MRI in effectiveness, says a leading rheumatologist. Professor David Hunter, Florance and Cope Chair of Rheumatology and Professor of Medicine at University of Sydney and the Royal ...
OA biomarkers showing promise but remain a research tool for now
By Amanda Sheppeard
22 Jul 2016